Kuros Biosciences Gains FDA Clearance for Intervertebral Body Fusion Device

Kuros Biosciences received FDA clearance to market the Kuros Transforaminal Lumbar Interbody Fusion cage. The device is to be used with KUR-113, the company's Fibrin-PTH product candidate for spinal fusion. Clinical trials of the system will now commence.

The cage is available in a range of sizes and cleared for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us